Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Nacubactam by NacuGen Therapeutics for Ventilator Associated Pneumonia (VAP): Likelihood of Approval
Nacubactam is under clinical development by NacuGen Therapeutics and currently in Phase III for Ventilator Associated Pneumonia (VAP). According to...
Nacubactam by NacuGen Therapeutics for Complicated Intra-Abdominal Infections: Likelihood of Approval
Nacubactam is under clinical development by NacuGen Therapeutics and currently in Phase III for Complicated Intra-Abdominal Infections. According to GlobalData,...
Nacubactam by NacuGen Therapeutics for Pyelonephritis: Likelihood of Approval
Nacubactam is under clinical development by NacuGen Therapeutics and currently in Phase III for Pyelonephritis. According to GlobalData, Phase III...
Nacubactam by NacuGen Therapeutics for Urinary Tract Infections: Likelihood of Approval
Nacubactam is under clinical development by NacuGen Therapeutics and currently in Phase III for Urinary Tract Infections. According to GlobalData,...